to explore a protective role for CD8+T cells in the anti-EMT6 tumor immune response, and assess a contrary role for CD4+Tregs, by characterizing the TILs and DLN cells in WT mice challenged with EMT6 and EMT6siCD200 tumors and treated with CD8 and CD4 depleting antibodies. Here, CD8A is linked to neoplasm.